1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow RP4010: new trials by email Literature Review of RP4010 trials Research Report on RP4010
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas RP4010 - Lymphoma | Phase 1 | Terminated | Rhizen Pharmaceuticals SA | 21 | 2017-05-11 | 2019-12-27 |
Lymphoma (1)
Australia (1) · United States (1)